Drug Type Small molecule drug |
Synonyms WYC-209 |
Target |
Action antagonists |
Mechanism RARα antagonists(Retinoic acid receptor alpha antagonists), RARβ2 antagonists(Retinoic acid receptor beta antagonists), RARγ antagonists(Retinoic acid receptor gamma antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | China | - | |
Melanoma | Preclinical | China | - | |
Intrahepatic Cholangiocarcinoma | Discovery | China | 28 Nov 2024 |